Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement

Sponsor
Kyunghee University Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03019562
Collaborator
(none)
46
1
2
12
3.8

Study Details

Study Description

Brief Summary

Oxycodone is one of the most widely used opioids for pain treatment. Many studies demonstrated good efficacy of oxycodone on postoperative pain. In this study, we assess the efficacy and side effects of bolus intravenous of oxycodone injection compared to those of fentanyl in patients after total hip replacement surgery.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Oxycodone is one of the most widely used opioids for pain treatment. There have been several studies on the efficacy and side effects of oxycodone. Oxycodone has been known to have the same potency with morphine. Many studies demonstrated good efficacy of oxycodone on postoperative pain. In this study, we designed a prospective, randomized, and double-blind study to assess the efficacy and side effects of bolus intravenous of oxycodone injection compared to those of fentanyl in patients who underwent the total hip replacement surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Oxycodone vs. Fentanyl in the Treatment of Early Postoperative Pain After Total Hip Replacement
Study Start Date :
Dec 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Oxycodone

4mg of oxycodone iv bolus

Drug: Oxycodone
4mg of oxycodone iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA)
Other Names:
  • Oxynorm
  • Active Comparator: Fentanyl

    50ug of fentanyl iv bolus

    Drug: Fentanyl
    50ug of fentanyl iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA),

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative pain measurement using Numeric Rating Scale(NRS) [Immediately after surgery]

      Measure postoperative pain using NRS at the PostAnesthesia Care Unit(PACU)

    Secondary Outcome Measures

    1. Additional doses of fentanyl for pain management [From immediately after surgery to 2 days after surgery]

      0-6 hours, 6-12 hours, 12-24 hours, 24-48 hours after surgery

    Other Outcome Measures

    1. Adverse effect [From immediately after surgery to 2 days after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 19-65 years of age

    • ASA physical status classification I or II

    • Scheduled for total hip replacement surgery

    Exclusion Criteria:
    • Allergic to study drugs

    • Patient with asthma or COPD, patient who is severely respiratory depressed

    • Renal of hepatic insufficiency

    • Epileptic status

    • Intracranial lesion associated with increased intracranial pressure

    • Acute abdomen, patient who has diagnosed paralytic ileus or suspicious ileus

    • Pregnant or lactating women

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kyung Hee University Hospital Seoul Korea, Republic of 02447

    Sponsors and Collaborators

    • Kyunghee University Medical Center

    Investigators

    • Principal Investigator: Mi Kyeong Kim, MD, PhD, Kyunghee University Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mi Kyeong Kim, Associate Professor, Kyunghee University Medical Center
    ClinicalTrials.gov Identifier:
    NCT03019562
    Other Study ID Numbers:
    • KHUH 2016-09-047
    First Posted:
    Jan 12, 2017
    Last Update Posted:
    Jan 12, 2017
    Last Verified:
    Jan 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Mi Kyeong Kim, Associate Professor, Kyunghee University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 12, 2017